Phase I/II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esoph...
Phase I/II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)
About this item
Full title
Author / Creator
Hironaka, Shuichi , Tsubosa, Yasuhiro , Mizusawa, Junki , Kii, Takayuki , Kato, Ken , Tsushima, Takahiro , Chin, Keisho , Tomori, Akihisa , Okuno, Tatsuya , Taniki, Toshikatsu , Ura, Takashi , Matsushita, Hisayuki , Kojima, Takashi , Doki, Yuichiro , Kusaba, Hitoshi , Fujitani, Kazumasa , Taira, Koichi , Seki, Shiko , Nakamura, Tsutomu , Kitagawa, Yuko and Japan Esophageal Oncology Group/Japan Clinical Oncology Group
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
We carried out a phase I/II trial of adding 2‐weekly docetaxel to cisplatin plus fluorouracil (CF) therapy (2‐weekly DCF regimen) in esophageal cancer patients to investigate its safety and antimetastatic activity. Patients received 2‐weekly docetaxel (30 mg/m2 [dose level (DL)1] or 40 mg/m2 [DL2] with a 3 + 3 design in phase I, on days 1 and 15) i...
Alternative Titles
Full title
Phase I/II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)
Authors, Artists and Contributors
Author / Creator
Tsubosa, Yasuhiro
Mizusawa, Junki
Kii, Takayuki
Kato, Ken
Tsushima, Takahiro
Chin, Keisho
Tomori, Akihisa
Okuno, Tatsuya
Taniki, Toshikatsu
Ura, Takashi
Matsushita, Hisayuki
Kojima, Takashi
Doki, Yuichiro
Kusaba, Hitoshi
Fujitani, Kazumasa
Taira, Koichi
Seki, Shiko
Nakamura, Tsutomu
Kitagawa, Yuko
Japan Esophageal Oncology Group/Japan Clinical Oncology Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4462397
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4462397
Other Identifiers
ISSN
1347-9032
E-ISSN
1349-7006
DOI
10.1111/cas.12486
